KLAC
58
-3
AFL
34
-8
CAG
41
7
CMCSA
35
8
HBAN
39
-9
AN
50
-2
T
33
-2
CNP
46
-3
SHW
33
-3
GILD
49
2
AMP
44
-8
AZO
52
-4
TSN
20
-2
AMT
24
-4
PPG
47
-3
TGNA
45
-3
LH
43
-2
ORCL
36
-6
FLR
46
-2
QRVO
30
-2
KLAC
58
-3
AFL
34
-8
CAG
41
7
CMCSA
35
8
HBAN
39
-9
AN
50
-2
T
33
-2
CNP
46
-3
SHW
33
-3
GILD
49
2
AMP
44
-8
AZO
52
-4
TSN
20
-2
AMT
24
-4
PPG
47
-3
TGNA
45
-3
LH
43
-2
ORCL
36
-6
FLR
46
-2
QRVO
30
-2
Financhill
Back

First Resources Vs. Kymera Therapeutics Industry Stock Comparison

Buy
75

FTROF
First Resources

Last Price:
$1.23
Seasonality Move:
0%
Sell
30

KYMR
Kymera Therapeutics

Last Price:
$38.17
Seasonality Move:
-10.26%
Buy
75
First Resources (FTROF) is a Buy

Is First Resources a Buy, Sell or Hold?

  • The current First Resources [FTROF] share price is $1.23. The Score for FTROF is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
  • FTROF is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
30
Kymera Therapeutics (KYMR) is a Sell

Is Kymera Therapeutics a Buy, Sell or Hold?

  • The current Kymera Therapeutics [KYMR] share price is $38.17. The Score for KYMR is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • KYMR is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

FTROF Stock Price Chart

What is First Resources's stock price today?

  • The First Resources share price today is $1.23
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FTROF is experiencing slight selling pressure.

KYMR Stock Price Chart

What is Kymera Therapeutics's stock price today?

  • The Kymera Therapeutics share price today is $38.17
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KYMR is experiencing slight selling pressure.

FTROF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.04 Sell
Relative Strength Index (14 RSI): 82.61 Buy
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.53 - 0.99) Buy
Bollinger Bands (100): (0.84 - 1.22) Buy

KYMR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.28 Sell
Relative Strength Index (14 RSI): 37.82 Sell
Chaikin Money Flow: -143789 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (39.55 - 43.99) Sell
Bollinger Bands (100): (42.38 - 48.84) Sell

FTROF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.71 Buy
20-day SMA: 0.67 Buy
50-day SMA: 0.96 Buy
200-day SMA: 1.07 Buy
8-day EMA: 0.77 Buy
20-day EMA: 0.76 Buy
50-day EMA: 0.89 Buy
200-day EMA: 0.04 Buy

KYMR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.19 Sell
20-day SMA: 40.94 Sell
50-day SMA: 44.31 Sell
200-day SMA: 41.26 Sell
8-day EMA: 40.12 Sell
20-day EMA: 41.22 Sell
50-day EMA: 43.16 Sell
200-day EMA: 41.01 Sell

First Resources Earnings Growth & FTROF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Kymera Therapeutics Earnings Growth & KYMR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.39 per share, and a decrease next year of $0.46 per share.

First Resources Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Kymera Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):